Literature DB >> 19787791

Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.

Luba Trakhtenbrot1, Izhar Hardan, Maya Koren-Michowitz, Shirley Oren, Galina Yshoev, Gideon Rechavi, Arnon Nagler, Ninette Amariglio.   

Abstract

Multiple myeloma (MM) is a malignancy of the plasma cells (PCs) characterized by a wide variety of genetic and chromosomal abnormalities. In recent years, major attention was drawn to the significance of chromosomal aberrations involving chromosome arm 13q and the IGH region on chromosome band 14q32 as a prognostic indicator in MM. In this study we applied a combined cell morphology and FISH method for the analysis of coexistence of t(11;14)(q13;q32) with deletions of the long arm of chromosome 13 (Delta13) in PCs from 51 MM patients using several probes for the 13q14, 11q13, and IGH regions. We found 15 different variants of the t(11;14) that are the consequence of different 11q13 breakpoints and various deletions of Variable (del IGH Var) or Constant (del IGH Const) IGH segments and also duplications and losses of the IGH gene on the normal nontranslocated chromosome 14 as well as IGH/Cyclin D1 (CCND1) fusion on der(14) and CCND1/IGH fusions on der(11). A strong association between Delta13 and specific variants of t(11;14) was found: variants with deletion of the IGH gene or its segments were found only in MM cases with deleted chromosome 13, while the common translocation t(11;14) was found only in the MM cases with normal chromosome arm 13q. In contrast, we did not find any association between Delta13 and deletions of the IGH gene or its segments in the MM patients with t(4;14)(p16;q32).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19787791     DOI: 10.1002/gcc.20716

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.

Authors:  Martin Schmidt-Hieber; María Laura Gutiérrez; Martin Pérez-Andrés; Bruno Paiva; Ana Rasillo; Maria Dolores Tabernero; José Maria Sayagués; Antonio Lopez; Paloma Bárcena; María Luz Sanchez; Norma C Gutiérrez; Jesus F San Miguel; Alberto Orfao
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

2.  Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death.

Authors:  Liat Josefsberg Ben-Yehoshua; Katia Beider; Avichai Shimoni; Olga Ostrovsky; Michal Samookh; Amnon Peled; Arnon Nagler
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

3.  Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.

Authors:  Jungwon Huh; Yeung Chul Mun; Eun Sun Yoo; Chu Myong Seong; Wha Soon Chung
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

4.  Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India

Authors:  Perumal Govindasamy; Prabu Pandurangan; Anil Tarigopula; Rama Mani; Chandra R Samuel
Journal:  Asian Pac J Cancer Prev       Date:  2019-01-25

5.  Expanding probe repertoire and improving reproducibility in human genomic hybridization.

Authors:  Stephanie N Dorman; Ben C Shirley; Joan H M Knoll; Peter K Rogan
Journal:  Nucleic Acids Res       Date:  2013-02-01       Impact factor: 16.971

6.  Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.

Authors:  Joanna C Dalland; James B Smadbeck; Neeraj Sharma; Reid G Meyer; Kathryn E Pearce; Patricia T Greipp; Jess F Peterson; Shaji Kumar; Rhett P Ketterling; Rebecca L King; Linda B Baughn
Journal:  Genes Chromosomes Cancer       Date:  2021-06-22       Impact factor: 5.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.